CN104189777A - Traditional Chinese medicine preparation for treating mastitis - Google Patents

Traditional Chinese medicine preparation for treating mastitis Download PDF

Info

Publication number
CN104189777A
CN104189777A CN201410485186.4A CN201410485186A CN104189777A CN 104189777 A CN104189777 A CN 104189777A CN 201410485186 A CN201410485186 A CN 201410485186A CN 104189777 A CN104189777 A CN 104189777A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
rhizoma
medicine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410485186.4A
Other languages
Chinese (zh)
Inventor
齐丽
曲艺
马文奇
刘玉峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qiqihar Medical University
Original Assignee
Qiqihar Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiqihar Medical University filed Critical Qiqihar Medical University
Priority to CN201410485186.4A priority Critical patent/CN104189777A/en
Publication of CN104189777A publication Critical patent/CN104189777A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation for treating the mastitis. The traditional Chinese medicine preparation is prepared from more than twenty Chinese herbal medicines such as Chinese thorowax root, radices paeoniae alba and the like. The traditional Chinese medicine preparation disclosed by the invention has the benefits that the traditional Chinese medicine preparation has the advantages of wide application range, obvious curative effect and stable long-term effect; by long-term clinical application, the traditional Chinese medicine preparation has an obvious treatment effect on mastitis.

Description

A kind of Chinese medicine preparation for the treatment of mastitis
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of mastitis.
Background technology
Mastitis refer to that the acute festering type of mammary gland infects, and are puerperal commonly encountered diseases, are one of reasons causing puerperal fever, are most commonly in nursing women, especially primipara.Any time of age of sucking all can occur, and the beginning of suckling is the most common.In the traditional Chinese medical science, mastitis are called " acute mastitis ", the cause of morbidity generally mostly is the blowing of sucking the breast by nursing infant, or nursing infant contains the newborn and infection wind and cold of sleeping, or because of hypergalactosis, nursing infant drinks less, or the nipple pain of breaking, and can not exhaust to nursing infant, or primipara breast network is not smooth, causes milk to be jammed due to interior, adding feelings will stimulates, the inducements such as rage melancholy, then depression of liver-QI, excessiveness of stomach-heat, place infantile dyspepsia is stagnant, becomes mutually carbuncle.Can be used at present that although the Chinese medicine of mastitis treatment is quite a few to be seen, evident in efficacy, and can accomplish that the stable medicine of long-term effect is actually rare.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of Chinese medicine preparation for the treatment of mastitis, and this medicine has applied widely, evident in efficacy, the advantage that long-term effect is stable.
Raw material of Chinese medicine composition and the weight portion proportioning of the present invention's treatment mastitis are:
Radix Bupleuri 15-20 part Radix Paeoniae Alba 30-50 part Rhizoma Corydalis 20-30 part
Radix Aucklandiae 15-25 part Rhizoma Chuanxiong 20-30 part Radix Curcumae 25-35 part
Fructus Toosendan 25-35 part Flos Lonicerae 40-60 part Rhizoma Sparganii 25-35 part
Rhizoma Curcumae 25-35 part Radix Angelicae Sinensis 25-35 part Pericarpium Citri Reticulatae Viride 25-35 part
Herba Taraxaci 25-35 part Olibanum 10-20 part Myrrha 10-20 part
25 parts of Fructus Aurantii 25-35 parts of Fructus Forsythiae 25-35 part Rhizoma Cyperi
Semen Persicae 10-20 part Flos Carthami 10-20 part Radix Glycyrrhizae 25-35 part
Below the property of medicine of the various raw materials of the invention described above medicine.
Radix Bupleuri: induce sweat bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.
The Radix Paeoniae Alba: nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.
Rhizoma Corydalis: promoting blood circulation to remove blood stasis, regulating QI to relieve pain.
The Radix Aucklandiae: circulation of qi promoting, pain relieving, spleen invigorating, helps digestion.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping.
Radix Curcumae: promoting QI circulation for relieving depression, removing heat from blood removing blood stasis with potent drugs.
Fructus Toosendan: soothing liver-QI promoting the circulation of QI to relieve pain, anthelmintic.
Flos Lonicerae; Dispelling wind-heat, removing summer-heat blood poison.
Rhizoma Sparganii: removing blood stasis, circulation of qi promoting, removing food stagnancy, pain relieving.
Rhizoma Curcumae: promoting the circulation of QI to relieve pain, removing blood stasis removing food stagnancy.
Radix Angelicae Sinensis: benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturizes laxation.
Pericarpium Citri Reticulatae Viride: soothing the liver dispelling the stagnated QI, eliminating stagnation expectorant.
Herba Taraxaci: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.
Olibanum: regulating qi and activating blood, analgesic therapy, chases after poison.
Myrrha: loose blood blood stasis removing, subduing swelling and relieving pain.
Fructus Forsythiae: heat-clearing and toxic substances removing, mass dissipating and swelling eliminating.
Rhizoma Cyperi: the resolving depression of regulating the flow of vital energy, pain relieving regulating menstruation.
Fructus Aurantii: dispelling the stagnated QI, row expectorant, removing food stagnancy.
Semen Persicae: blood stasis removing and clots absorbing, moisturize laxation.
Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.
Radix Glycyrrhizae: heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription.
The preparation of medicine of the present invention and instructions of taking are to choose 300 to 400 grams of medicine materials in prescription ratio: medicine is cleaned, add cold water 2000ml to soak half an hour, big fire is boiled, at a simmer to 100ml, medicine juice is leached, then the 2000ml cold water that adds water, decoct to 100ml, leach with last time medicine juice mix into together with, sooner or later sub-service, each 100ml.
The invention has the beneficial effects as follows: this medicine has applied widely the advantage that curative effect is obvious and long-term effect is stable.After Drug therapy of the present invention, occur that more afterwards the case history of recurrence is very rare again.
Detailed description of the invention
Example 1
Raw material composition and the weight portion proportioning of medicine of the present invention are:
20 parts of 30 parts of Rhizoma Corydalis of 15 portions of Radix Paeoniae Albas of Radix Bupleuri
25 parts of 20 portions of Radix Curcumaes of 20 parts of Rhizoma Chuanxiong of the Radix Aucklandiae
30 parts of 40 parts of Rhizoma Sparganii of 25 portions of Flos Loniceraes of Fructus Toosendan
25 parts, 30 parts of Pericarpium Citri Reticulatae Virides of 25 parts of Radix Angelicae Sinensis of Rhizoma Curcumae
10 parts of 15 parts of Myrrhas of 30 parts of Olibanums of Herba Taraxaci
25 parts of 25 parts of Fructus Aurantiis of 25 portions of Rhizoma Cyperis of Fructus Forsythiae
25 parts, 10 portions of Radix Glycyrrhizaes of 10 parts of Flos Carthamis of Semen Persicae
Example 2
Raw material composition and the weight portion proportioning of medicine of the present invention are:
30 parts of 40 parts of Rhizoma Corydalis of 20 portions of Radix Paeoniae Albas of Radix Bupleuri
35 parts of 20 portions of Radix Curcumaes of 25 parts of Rhizoma Chuanxiong of the Radix Aucklandiae
30 parts of 40 parts of Rhizoma Sparganii of 35 portions of Flos Loniceraes of Fructus Toosendan
30 parts, 35 parts of Pericarpium Citri Reticulatae Virides of 35 parts of Radix Angelicae Sinensis of Rhizoma Curcumae
20 parts of 20 parts of Myrrhas of 30 parts of Olibanums of Herba Taraxaci
25 parts of 25 parts of Fructus Aurantiis of 35 portions of Rhizoma Cyperis of Fructus Forsythiae
35 parts, 20 portions of Radix Glycyrrhizaes of 20 parts of Flos Carthamis of Semen Persicae
Example 3
Raw material composition and the weight portion proportioning of medicine of the present invention are:
30 parts of 30 parts of Rhizoma Corydalis of 20 portions of Radix Paeoniae Albas of Radix Bupleuri
30 parts of 20 portions of Radix Curcumaes of 15 parts of Rhizoma Chuanxiong of the Radix Aucklandiae
30 parts of 50 parts of Rhizoma Sparganii of 35 portions of Flos Loniceraes of Fructus Toosendan
30 parts, 20 parts of Pericarpium Citri Reticulatae Virides of 35 parts of Radix Angelicae Sinensis of Rhizoma Curcumae
15 parts of 15 parts of Myrrhas of 25 parts of Olibanums of Herba Taraxaci
25 parts of 25 parts of Fructus Aurantiis of 30 portions of Rhizoma Cyperis of Fructus Forsythiae
30 parts, 20 portions of Radix Glycyrrhizaes of 10 parts of Flos Carthamis of Semen Persicae
Example 4
Raw material composition and the weight portion proportioning of medicine of the present invention are:
25 parts of 40 parts of Rhizoma Corydalis of 20 portions of Radix Paeoniae Albas of Radix Bupleuri
35 parts of 20 portions of Radix Curcumaes of 25 parts of Rhizoma Chuanxiong of the Radix Aucklandiae
35 parts of 60 parts of Rhizoma Sparganii of 30 portions of Flos Loniceraes of Fructus Toosendan
35 parts, 30 parts of Pericarpium Citri Reticulatae Virides of 25 parts of Radix Angelicae Sinensis of Rhizoma Curcumae
20 parts of 20 parts of Myrrhas of 30 parts of Olibanums of Herba Taraxaci
35 parts of 25 parts of Fructus Aurantiis of 25 portions of Rhizoma Cyperis of Fructus Forsythiae
10 parts of Flos Carthamis 15 of Semen Persicae.30 parts, part Radix Glycyrrhizae
Example 5
The present invention is applicable to treat various mastitis, treats altogether for many years patient's 136 examples, and total effective rate is 97%, cure rate 80%.
In table, the standard for the treatment of recovery from illness is; Distending pain, local skin temperature are high, tenderness transference cure, and local scleroma disappears;
Treating effective criterion is; Distending pain, local skin temperature are high, and tenderness symptom alleviates, and local scleroma diminishes.
The criterion of failing to respond to any medical treatment is: symptom and sign are without obvious change.
Treatment efficacy analysis of the present invention
? Treatment number Recovery from illness number Efficiently individual quantity Invalid number
The embodiment of the present invention 1 32 23 8 1
The embodiment of the present invention 2 29 25 4 ?
The embodiment of the present invention 3 44 36 6 2
The embodiment of the present invention 4 31 25 5 1
? 136 109 23 4

Claims (1)

1. a Chinese medicine preparation for the treatment of mastitis, is characterized in that: this medicine material composition and weight portion proportioning are:
Radix Bupleuri 15-20 part Radix Paeoniae Alba 30-50 part Rhizoma Corydalis 20-30 part
Radix Aucklandiae 15-25 part Rhizoma Chuanxiong 20-30 part Radix Curcumae 25-35 part
Fructus Toosendan 25-35 part Flos Lonicerae 40-60 part Rhizoma Sparganii 25-35 part
Rhizoma Curcumae 25-35 part Radix Angelicae Sinensis 25-35 part Pericarpium Citri Reticulatae Viride 25-35 part
Herba Taraxaci 25-35 part Olibanum 10-20 part Myrrha 10-20 part
25 parts of Fructus Aurantii 25-35 parts of Fructus Forsythiae 25-35 part Rhizoma Cyperi
Semen Persicae 10-20 part Flos Carthami 10-20 part Radix Glycyrrhizae 25-35 part.
CN201410485186.4A 2014-09-22 2014-09-22 Traditional Chinese medicine preparation for treating mastitis Pending CN104189777A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410485186.4A CN104189777A (en) 2014-09-22 2014-09-22 Traditional Chinese medicine preparation for treating mastitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410485186.4A CN104189777A (en) 2014-09-22 2014-09-22 Traditional Chinese medicine preparation for treating mastitis

Publications (1)

Publication Number Publication Date
CN104189777A true CN104189777A (en) 2014-12-10

Family

ID=52075248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410485186.4A Pending CN104189777A (en) 2014-09-22 2014-09-22 Traditional Chinese medicine preparation for treating mastitis

Country Status (1)

Country Link
CN (1) CN104189777A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104623244A (en) * 2015-02-04 2015-05-20 济南骄泰信息技术有限公司 Clinical-care traditional Chinese medicine composition for treating mastitis
CN105381398A (en) * 2015-11-20 2016-03-09 薛学明 Medicine for treating mastitis and preparation method of medicine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101926956A (en) * 2009-06-24 2010-12-29 许东群 Chinese medicinal powder for treating mazoitis, hyperplasia of mammary glands and breast cancer
CN101972444A (en) * 2010-07-13 2011-02-16 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating mastitis and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101926956A (en) * 2009-06-24 2010-12-29 许东群 Chinese medicinal powder for treating mazoitis, hyperplasia of mammary glands and breast cancer
CN101972444A (en) * 2010-07-13 2011-02-16 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating mastitis and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104623244A (en) * 2015-02-04 2015-05-20 济南骄泰信息技术有限公司 Clinical-care traditional Chinese medicine composition for treating mastitis
CN105381398A (en) * 2015-11-20 2016-03-09 薛学明 Medicine for treating mastitis and preparation method of medicine

Similar Documents

Publication Publication Date Title
CN103110844B (en) Traditional Chinese medicine for treating acute tonsillitis
CN102100872A (en) Chinese medicine preparation for treating mastitis
CN103736018A (en) Medicine for treating gallstones and preparation method thereof
CN104784660A (en) Stasis removing soup for lobular hyperplasia
CN104623362A (en) Traditional Chinese medicine composition for treating depression
CN104189777A (en) Traditional Chinese medicine preparation for treating mastitis
CN105381153A (en) Traditional Chinese medicine preparation for treating bronchitis and preparation method thereof
CN104825561A (en) Traditional Chinese medicine for treating arthritis
CN104027522A (en) Traditional Chinese medicament for treating acute appendicitis
CN103432533B (en) Traditional Chinese medicine for treating perianal abscess
CN105497651A (en) Traditional Chinese medicine for treating acute mastitis
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN104189511A (en) Traditional Chinese medicine preparation for treating chronic cholecystitis
CN104258299A (en) Traditional Chinese medicine for treating mumps
CN103768368A (en) Traditional Chinese medicine composition for treating acute epididymitis
CN104225282A (en) Traditional Chinese medicine for treating postpartum headache
CN103585263A (en) Traditional Chinese medicine composition for treating chronic suppurative otitis media and preparation method thereof
CN103893675A (en) Traditional Chinese medicinal preparation for treating epigastric pain
CN101979072A (en) Chinese medicament for treating chronic liver disease
CN101693095A (en) Traditional Chinese medicine preparation for treating cirrhosis and liver ascites
CN105920292A (en) Chinese medicinal composition for treating acute mastitis
CN104258233A (en) Traditional Chinese medicine for treating impetigo
CN105381207A (en) Traditional Chinese medicine composition for treating swelling and pain in throat
CN103977239A (en) Traditional Chinese medicine preparation for treating chronic pharyngitis and preparation method thereof
CN105055740A (en) Traditional Chinese medicine pharmaceutical for treating heartburn

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141210

RJ01 Rejection of invention patent application after publication